Last week, Nvidia Corp (NASDAQ:NVDA) announced significant collaborations with Johnson & Johnson (NYSE:JNJ) and General Electric Co (NYSE:GE) GE Healthcare to integrate generative AI into surgery and enhance medical imaging.
The company flagged the partnerships at Nvidia’s 2024 GTC AI conference, where the company unveiled about two dozen new AI-based healthcare tools, marking a significant push into the medical sector.
Raj Joshi from Moody’s Ratings emphasized Nvidia’s crucial role in facilitating previously complex tasks in healthcare, indicating the sector’s potential for Nvidia’s revenue outside the tech sphere, CNBC reports.
Also Read: Nvidia’s Groundbreaking AI Innovations at GTC 2024 Spark Analyst Enthusiasm
Nvidia’s shares have surged by nearly 100% year-to-date, with the biotech industry showcasing the untapped potential for ...